| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.92e-04 | 560 | 31 | 6 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 2.03e-04 | 566 | 31 | 6 | GO:0001216 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 1.11e-03 | 1412 | 31 | 8 | GO:0000981 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1.38e-03 | 1459 | 31 | 8 | GO:0000977 | |
| GeneOntologyMolecularFunction | protease binding | 2.73e-03 | 181 | 31 | 3 | GO:0002020 | |
| MousePheno | inner ear cyst | 3.32e-05 | 5 | 26 | 2 | MP:0006287 | |
| MousePheno | abnormal urinary system development | 4.92e-05 | 111 | 26 | 4 | MP:0003942 | |
| MousePheno | podocyte microvillus transformation | 6.95e-05 | 7 | 26 | 2 | MP:0011868 | |
| MousePheno | increased urine protein level | 1.54e-04 | 149 | 26 | 4 | MP:0002962 | |
| Pathway | REACTOME_KIDNEY_DEVELOPMENT | 9.00e-05 | 46 | 27 | 3 | M48243 | |
| Pubmed | Higher-Order Kidney Organogenesis from Pluripotent Stem Cells. | 2.01e-07 | 13 | 32 | 3 | 29129523 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 19856421 | ||
| Pubmed | Dependence of nodal sodium channel clustering on paranodal axoglial contact in the developing CNS. | 8.20e-07 | 2 | 32 | 2 | 10460258 | |
| Pubmed | Conserved and Divergent Molecular and Anatomic Features of Human and Mouse Nephron Patterning. | 1.08e-06 | 22 | 32 | 3 | 29449451 | |
| Pubmed | 1.81e-06 | 26 | 32 | 3 | 28720576 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 25917456 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 38299390 | ||
| Pubmed | Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study. | 2.46e-06 | 3 | 32 | 2 | 30552067 | |
| Pubmed | 4.06e-06 | 263 | 32 | 5 | 34702444 | ||
| Pubmed | Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition. | 4.92e-06 | 4 | 32 | 2 | 26598551 | |
| Pubmed | CrkRS: a novel conserved Cdc2-related protein kinase that colocalises with SC35 speckles. | 4.92e-06 | 4 | 32 | 2 | 11683387 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 25556170 | ||
| Pubmed | 6.83e-06 | 40 | 32 | 3 | 30865227 | ||
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 23690623 | ||
| Pubmed | Ermin, a myelinating oligodendrocyte-specific protein that regulates cell morphology. | 8.19e-06 | 5 | 32 | 2 | 16421295 | |
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 16908628 | ||
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 29689192 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 1.23e-05 | 877 | 32 | 7 | 20211142 | |
| Pubmed | SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. | 1.72e-05 | 7 | 32 | 2 | 15235609 | |
| Pubmed | A Novel Role for GATA3 in Mesangial Cells in Glomerular Development and Injury. | 1.72e-05 | 7 | 32 | 2 | 31405951 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 28118374 | ||
| Pubmed | 2.23e-05 | 180 | 32 | 4 | 24104479 | ||
| Pubmed | Hox11 paralogous genes are essential for metanephric kidney induction. | 2.29e-05 | 8 | 32 | 2 | 12050119 | |
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 18490449 | ||
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 25762662 | ||
| Pubmed | AMOTL2 mono-ubiquitination by WWP1 promotes contact inhibition by facilitating LATS activation. | 2.29e-05 | 8 | 32 | 2 | 34404733 | |
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 27160901 | ||
| Pubmed | A uniform procedure for the purification of CDK7/CycH/MAT1, CDK8/CycC and CDK9/CycT1. | 2.94e-05 | 9 | 32 | 2 | 15328539 | |
| Pubmed | 3.67e-05 | 10 | 32 | 2 | 26936881 | ||
| Pubmed | The centrosomal protein Lats2 is a phosphorylation target of Aurora-A kinase. | 4.49e-05 | 11 | 32 | 2 | 15147269 | |
| Pubmed | 4.49e-05 | 11 | 32 | 2 | 29444422 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 4.64e-05 | 1489 | 32 | 8 | 28611215 | |
| Pubmed | 5.13e-05 | 446 | 32 | 5 | 24255178 | ||
| Pubmed | 5.38e-05 | 12 | 32 | 2 | 37439314 | ||
| Pubmed | Molecular mechanisms underlying inner ear patterning defects in kreisler mutants. | 5.38e-05 | 12 | 32 | 2 | 16325169 | |
| Pubmed | 5.38e-05 | 12 | 32 | 2 | 36402907 | ||
| Pubmed | Comprehensive transcriptome analysis of cochlear spiral ganglion neurons at multiple ages. | 5.38e-05 | 12 | 32 | 2 | 31913118 | |
| Pubmed | CNS myelin paranodes require Nkx6-2 homeoprotein transcriptional activity for normal structure. | 6.36e-05 | 13 | 32 | 2 | 15601927 | |
| Pubmed | A Point Mutation in p190A RhoGAP Affects Ciliogenesis and Leads to Glomerulocystic Kidney Defects. | 6.36e-05 | 13 | 32 | 2 | 26859289 | |
| Pubmed | 6.36e-05 | 13 | 32 | 2 | 36793543 | ||
| Pubmed | WAVE1 is required for oligodendrocyte morphogenesis and normal CNS myelination. | 6.36e-05 | 13 | 32 | 2 | 16723544 | |
| Pubmed | A Second Heart Field-Derived Vasculogenic Niche Contributes to Cardiac Lymphatics. | 6.36e-05 | 13 | 32 | 2 | 31928974 | |
| Pubmed | Cardiac deletion of Smyd2 is dispensable for mouse heart development. | 6.36e-05 | 13 | 32 | 2 | 20305823 | |
| Pubmed | 7.41e-05 | 14 | 32 | 2 | 24327562 | ||
| Pubmed | Hoxa11 and Hoxd11 regulate branching morphogenesis of the ureteric bud in the developing kidney. | 7.41e-05 | 14 | 32 | 2 | 11493536 | |
| Pubmed | Hoxb3 negatively regulates Hoxb1 expression in mouse hindbrain patterning. | 7.41e-05 | 14 | 32 | 2 | 21320481 | |
| Pubmed | 7.41e-05 | 14 | 32 | 2 | 29183995 | ||
| Pubmed | 7.41e-05 | 14 | 32 | 2 | 31242448 | ||
| Pubmed | OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ. | 8.13e-05 | 91 | 32 | 3 | 30472188 | |
| Pubmed | FGF8 is essential for formation of the ductal system in the male reproductive tract. | 8.55e-05 | 15 | 32 | 2 | 22110055 | |
| Pubmed | 8.55e-05 | 15 | 32 | 2 | 7543410 | ||
| Pubmed | β-catenin regulates the formation of multiple nephron segments in the mouse kidney. | 8.55e-05 | 15 | 32 | 2 | 31685872 | |
| Pubmed | 9.76e-05 | 16 | 32 | 2 | 23762375 | ||
| Pubmed | 9.76e-05 | 16 | 32 | 2 | 15829521 | ||
| Pubmed | 9.76e-05 | 16 | 32 | 2 | 9817915 | ||
| Pubmed | 9.76e-05 | 16 | 32 | 2 | 23840809 | ||
| Pubmed | 1.11e-04 | 17 | 32 | 2 | 19372141 | ||
| Pubmed | 1.11e-04 | 17 | 32 | 2 | 32393787 | ||
| Pubmed | Conserved and Divergent Features of Human and Mouse Kidney Organogenesis. | 1.11e-04 | 17 | 32 | 2 | 29449453 | |
| Pubmed | 1.24e-04 | 18 | 32 | 2 | 23426694 | ||
| Pubmed | Six1 regulates Grem1 expression in the metanephric mesenchyme to initiate branching morphogenesis. | 1.24e-04 | 18 | 32 | 2 | 21281623 | |
| Pubmed | 1.24e-04 | 18 | 32 | 2 | 14628042 | ||
| Pubmed | 1.24e-04 | 18 | 32 | 2 | 30456369 | ||
| Pubmed | 1.24e-04 | 18 | 32 | 2 | 29113990 | ||
| Pubmed | 1.39e-04 | 19 | 32 | 2 | 21858105 | ||
| Pubmed | 1.39e-04 | 19 | 32 | 2 | 34478649 | ||
| Pubmed | 1.39e-04 | 19 | 32 | 2 | 16319112 | ||
| Pubmed | Cep120 is essential for kidney stromal progenitor cell growth and differentiation. | 1.39e-04 | 19 | 32 | 2 | 38177914 | |
| Pubmed | Independent functions and mechanisms for homeobox gene Barx1 in patterning mouse stomach and spleen. | 1.39e-04 | 19 | 32 | 2 | 17855428 | |
| Pubmed | 1.54e-04 | 20 | 32 | 2 | 20040500 | ||
| Pubmed | 1.54e-04 | 20 | 32 | 2 | 16009131 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 1.58e-04 | 908 | 32 | 6 | 19274049 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 1.61e-04 | 569 | 32 | 5 | 30639242 | |
| Pubmed | 1.70e-04 | 21 | 32 | 2 | 29324782 | ||
| Pubmed | Major β cell-specific functions of NKX2.2 are mediated via the NK2-specific domain. | 1.87e-04 | 22 | 32 | 2 | 37364986 | |
| Pubmed | 2.05e-04 | 23 | 32 | 2 | 28071588 | ||
| Pubmed | Transcription Factor MafB Coordinates Epidermal Keratinocyte Differentiation. | 2.24e-04 | 24 | 32 | 2 | 27208706 | |
| Pubmed | 2.43e-04 | 25 | 32 | 2 | 21145499 | ||
| Pubmed | 2.63e-04 | 26 | 32 | 2 | 34301885 | ||
| Pubmed | Lats1 and Lats2 are required for the maintenance of multipotency in the Müllerian duct mesenchyme. | 2.84e-04 | 27 | 32 | 2 | 31575647 | |
| Pubmed | 3.28e-04 | 29 | 32 | 2 | 27120339 | ||
| Pubmed | 3.75e-04 | 31 | 32 | 2 | 36362374 | ||
| Pubmed | Sox11 gene disruption causes congenital anomalies of the kidney and urinary tract (CAKUT). | 3.75e-04 | 31 | 32 | 2 | 29459093 | |
| Pubmed | 4.00e-04 | 32 | 32 | 2 | 17267499 | ||
| Pubmed | Convergence of the insulin and serotonin programs in the pancreatic β-cell. | 4.52e-04 | 34 | 32 | 2 | 22013016 | |
| Pubmed | 4.77e-04 | 1116 | 32 | 6 | 31753913 | ||
| Pubmed | 5.07e-04 | 36 | 32 | 2 | 27736991 | ||
| Pubmed | β-Cell-Specific Mafk Overexpression Impairs Pancreatic Endocrine Cell Development. | 5.07e-04 | 36 | 32 | 2 | 26901059 | |
| Pubmed | Quantifying domain-ligand affinities and specificities by high-throughput holdup assay. | 5.07e-04 | 36 | 32 | 2 | 26053890 | |
| Pubmed | 5.35e-04 | 37 | 32 | 2 | 35918150 | ||
| Pubmed | 5.35e-04 | 37 | 32 | 2 | 39178848 | ||
| Pubmed | 5.65e-04 | 38 | 32 | 2 | 27820600 | ||
| Pubmed | Defining the molecular character of the developing and adult kidney podocyte. | 5.95e-04 | 39 | 32 | 2 | 21931791 | |
| Pubmed | 6.26e-04 | 40 | 32 | 2 | 23362348 | ||
| Pubmed | 6.58e-04 | 41 | 32 | 2 | 30377232 | ||
| Pubmed | 6.76e-04 | 187 | 32 | 3 | 26460568 | ||
| Pubmed | 6.90e-04 | 42 | 32 | 2 | 24997765 | ||
| Pubmed | 6.90e-04 | 42 | 32 | 2 | 15146195 | ||
| Pubmed | 7.57e-04 | 44 | 32 | 2 | 37682711 | ||
| Pubmed | NANOG initiates epiblast fate through the coordination of pluripotency genes expression. | 8.28e-04 | 46 | 32 | 2 | 35729116 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | 4.98e-06 | 854 | 31 | 8 | M1533 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | 6.63e-06 | 888 | 31 | 8 | MM1018 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | 2.12e-05 | 493 | 31 | 6 | M1951 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | 2.40e-05 | 504 | 31 | 6 | MM830 | |
| Coexpression | GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP | 4.27e-05 | 166 | 31 | 4 | M7722 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP | 5.62e-05 | 587 | 31 | 6 | M40869 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_UP | 8.47e-05 | 198 | 31 | 4 | M4418 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP | 8.64e-05 | 199 | 31 | 4 | M3478 | |
| Coexpression | GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP | 8.81e-05 | 200 | 31 | 4 | M6242 | |
| Coexpression | GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP | 8.81e-05 | 200 | 31 | 4 | M5668 | |
| Coexpression | ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF | 1.56e-04 | 232 | 31 | 4 | M2613 | |
| Coexpression | SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA | 1.81e-04 | 93 | 31 | 3 | M42516 | |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_top-relative-expression-ranked_1000 | 2.00e-05 | 838 | 31 | 8 | gudmap_kidney_adult_Podocyte_MafB_1000 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K2 | 3.68e-05 | 441 | 31 | 6 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K2 | |
| ToppCell | Mild/Remission-B_intermediate-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.58e-06 | 123 | 31 | 4 | 69b7f2f4604bf221a0ff581c51de743e8a4c0537 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Mesenchymal-Mes-Myofibroblast|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.72e-06 | 170 | 31 | 4 | 489fc97f6002a577b882a8ff3c563b1e42041d38 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Mesenchymal-Mes-Myofibroblast-VLMC_L1-3_CYP1B1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.72e-06 | 170 | 31 | 4 | 7d736e741799b67a7f022fc6766841c951ef8951 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.02e-05 | 197 | 31 | 4 | ad702e440a74d54cfdcb8bb1c66bd8e0e71ab04e | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.58e-05 | 100 | 31 | 3 | 1de3895e16f14ff32b901b18ce14d965afaa7e76 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.58e-05 | 100 | 31 | 3 | 20675fc2ffc5ab63047d38da083b50d470f3db19 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.58e-05 | 100 | 31 | 3 | ff1bdb511700a041a90034d1d30dfc25f51d6c82 | |
| ToppCell | Thalamus|World / BrainAtlas - Mouse McCarroll V32 | 7.12e-05 | 116 | 31 | 3 | 5ddfb2dd5459ff6d7ae38163a38eae64fda283b7 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.17e-04 | 137 | 31 | 3 | 80f1a6cfb48ccfba1c3545fdcd5fcb3157272aca | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-Treg|Leuk-UTI / Disease, Lineage and Cell Type | 1.62e-04 | 153 | 31 | 3 | b24c693b142206d13b29c96faa7f79a1a22bc2ef | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 156 | 31 | 3 | 5caefdc6cc86f2ac52abe8c8da821db14f476915 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 156 | 31 | 3 | 758f57dc10fc5cad200bf5b310c10ec9b1405f23 | |
| ToppCell | Severe-B_naive-5|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.74e-04 | 157 | 31 | 3 | a57ee4a6febdff3ee3d1645836695e6e7c055cf8 | |
| ToppCell | TCGA-Kidney-Solid_Tissue_Normal-Kidney-Kidney_normal_tissue-5|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.78e-04 | 158 | 31 | 3 | 34b284a62cc3fb90429ce579fd8cb8a60178091b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-04 | 159 | 31 | 3 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.84e-04 | 160 | 31 | 3 | dd16ca90feb3ae88b6409d6c278b4765da565514 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-04 | 167 | 31 | 3 | b4ef07117d14da3d5fbced949e4dfcb01c392295 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-04 | 167 | 31 | 3 | 94fc7df7ca55cd722a8dbd153201a29891217473 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-04 | 167 | 31 | 3 | eff3723fe60755272eca237459165e436e919ece | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 170 | 31 | 3 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 170 | 31 | 3 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Mesenchymal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-04 | 171 | 31 | 3 | 4df4ee91fb9672f6541bd62dc0fb099fe014a65c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Mesenchymal-Mes|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-04 | 171 | 31 | 3 | c2a211352411c84e323175998f8a6d3fea77313b | |
| ToppCell | facs-Skin-nan-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 172 | 31 | 3 | 5ca89af7406e7e1a055dd60d6f89615f69e62324 | |
| ToppCell | Frontal_cortex-Macroglia|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.32e-04 | 173 | 31 | 3 | ac70145e093ef0df43811e7c67a865ccdd45a5e3 | |
| ToppCell | Posterior_cortex-Macroglia|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.40e-04 | 175 | 31 | 3 | 8bc7a3856d04692989b2a1675ea6d9392261d55a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-04 | 175 | 31 | 3 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | BAL-Mild-cDC_3|Mild / Compartment, Disease Groups and Clusters | 2.44e-04 | 176 | 31 | 3 | f9b0c3ced391e7ebe6b242d3f12ba14741f88d22 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 177 | 31 | 3 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.48e-04 | 177 | 31 | 3 | eb0cfe8e9a91910f9979608ed47add48d98ce4dd | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 177 | 31 | 3 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.52e-04 | 178 | 31 | 3 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.52e-04 | 178 | 31 | 3 | b1357ceb84b83fab53c0394c1af73cbd009f571a | |
| ToppCell | Globus_pallidus-Macroglia|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.56e-04 | 179 | 31 | 3 | ab50f711b004b96107f813c9a2526ec21d1c8027 | |
| ToppCell | Entopeduncular-Macroglia|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.56e-04 | 179 | 31 | 3 | f61974710a60aa0618fdb30d864fb9bc7c05ef21 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-04 | 181 | 31 | 3 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-04 | 181 | 31 | 3 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.69e-04 | 182 | 31 | 3 | 9ba85f621a846531a2a7861e9df695d288c9e149 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 182 | 31 | 3 | c00e503f442d44fbae73c5e2dc85be69e294e67a | |
| ToppCell | RSV-Healthy-5|Healthy / Virus stimulation, Condition and Cluster | 2.78e-04 | 184 | 31 | 3 | 1e282d619ef8035437fabe0fd2aefda1c142f7f6 | |
| ToppCell | RSV-Healthy-5|RSV / Virus stimulation, Condition and Cluster | 2.78e-04 | 184 | 31 | 3 | ba958f731de6c9eff60103d483e020e2c0c7af7c | |
| ToppCell | control-Others-Megakaryocytes|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.78e-04 | 184 | 31 | 3 | 213915f2889ce8ecbe5f7b19bc2b24ed8c5efe1d | |
| ToppCell | control-Others|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.78e-04 | 184 | 31 | 3 | a63b39fcc570b554cf10e8e47c2c1e079034768f | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.87e-04 | 186 | 31 | 3 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | severe-Others|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.87e-04 | 186 | 31 | 3 | 234a4bc7c3529daf8804f2a366887d02a47075cd | |
| ToppCell | severe-Others-Megakaryocytes|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.92e-04 | 187 | 31 | 3 | ef16331d1e5abe6bde7f09793c4a87a6ac24e592 | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.96e-04 | 188 | 31 | 3 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-04 | 188 | 31 | 3 | e99e3765b48392c987cf0c5ccbded0655637d7b7 | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.96e-04 | 188 | 31 | 3 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | severe_influenza-CD4+_Tcm|severe_influenza / disease group, cell group and cell class (v2) | 2.96e-04 | 188 | 31 | 3 | 633e5545f49b1b864b0ffa5fc9688d270690f884 | |
| ToppCell | Endothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor | 2.96e-04 | 188 | 31 | 3 | 80910dcbb51990f2baed240f319456c0d3fa2065 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.96e-04 | 188 | 31 | 3 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.96e-04 | 188 | 31 | 3 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 3.01e-04 | 189 | 31 | 3 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | Healthy/Control-Platelet|Healthy/Control / Disease group and Cell class | 3.01e-04 | 189 | 31 | 3 | 3de7f8d8b8451ed9a146cce499552e9a060e9099 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.01e-04 | 189 | 31 | 3 | f7e9b6e6a4de297b660a5b6c9a62f860c147185e | |
| ToppCell | mild-Others|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.05e-04 | 190 | 31 | 3 | 782dc1b612ac1faad7cc2781bfda92a079830d38 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.05e-04 | 190 | 31 | 3 | 6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.05e-04 | 190 | 31 | 3 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-04 | 191 | 31 | 3 | c5ef34d138cd797029dfefaf4c52d16ba6a76c38 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.10e-04 | 191 | 31 | 3 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.10e-04 | 191 | 31 | 3 | 9c747f8cc1cdce45e839b661d782e1e8cfb79578 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-04 | 192 | 31 | 3 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | COVID-19-kidney-CNT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.15e-04 | 192 | 31 | 3 | 760c6b9628de9693034b00c5025c5c4df94bb2e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-04 | 192 | 31 | 3 | 0bb06738e1c3ec0c044a7ee61f6cf1d4781fb53c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.15e-04 | 192 | 31 | 3 | 7ab626a516b07d899175ff12f1c8257688324e4b | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 3.20e-04 | 193 | 31 | 3 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.20e-04 | 193 | 31 | 3 | 194b49c152e3e3f599068ec88a7f0af6427b743a | |
| ToppCell | COVID-19_Mild-CD4+_Tcm|COVID-19_Mild / Disease condition and Cell class | 3.25e-04 | 194 | 31 | 3 | 3be2b1c81e668ffdf593ff41d3ba211c26d77671 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 3.25e-04 | 194 | 31 | 3 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-04 | 194 | 31 | 3 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.25e-04 | 194 | 31 | 3 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 3.25e-04 | 194 | 31 | 3 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.25e-04 | 194 | 31 | 3 | a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.30e-04 | 195 | 31 | 3 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.30e-04 | 195 | 31 | 3 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_Tcm|World / disease group, cell group and cell class (v2) | 3.30e-04 | 195 | 31 | 3 | a72bb5b1b15dd1ab70ced5622d94499caff8bb6b | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.34e-04 | 196 | 31 | 3 | c2bbb48c4aa979b03cb6f4ce9f351f492977c992 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.34e-04 | 196 | 31 | 3 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-Gamma_Delta_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.34e-04 | 196 | 31 | 3 | 6eabbac1625f715531bae562a28da27664572600 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.34e-04 | 196 | 31 | 3 | 64c2abc0087bf2ae547932377f3662e3be1cc63e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-04 | 196 | 31 | 3 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | COPD-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 3.34e-04 | 196 | 31 | 3 | c9bdd505c3ab380ed7b272aa518df31a0a706a06 | |
| ToppCell | distal-Endothelial-Lymphatic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.34e-04 | 196 | 31 | 3 | b0f23dc802a2c2a56a08d398a464ea78b58ade4c | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD4+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.40e-04 | 197 | 31 | 3 | c842d169dfce9af3ed7c01dc7e940c0bdd21388c | |
| ToppCell | healthy_donor-Lymphocytic-T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.40e-04 | 197 | 31 | 3 | 63d0f06e150e7eb800ecb70e97b9d12a01c84e37 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.45e-04 | 198 | 31 | 3 | 58f208b76cb0adcecdf632d92f92833a06f9bf71 | |
| ToppCell | Skin|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 3.50e-04 | 199 | 31 | 3 | 6be1340413ee868c610b6e3f58c65b493eb22bb5 | |
| ToppCell | mild-CD4+_Tcm|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.50e-04 | 199 | 31 | 3 | 06c8a0e39f7a33736548f04a5e2263334c8541cf | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-04 | 200 | 31 | 3 | f0c338877e39226a90c4effe12f6501d33542a73 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-04 | 200 | 31 | 3 | 56f1f007ba8c9188a4b10e52744f1e50dc0f155a | |
| ToppCell | Skin-Keratinocytes|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 3.55e-04 | 200 | 31 | 3 | 59d72395199bc30df0e811fbc99149694e208860 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 3.55e-04 | 200 | 31 | 3 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| Drug | YS19 | 1.79e-06 | 2 | 31 | 2 | CID000200844 | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 6.69e-06 | 198 | 31 | 5 | 3175_DN | |
| Drug | STOCK1N-28457; Up 200; 20uM; MCF7; HT_HG-U133A | 6.85e-06 | 199 | 31 | 5 | 6869_UP | |
| Drug | Endyinasl | 1.79e-05 | 5 | 31 | 2 | CID005492616 | |
| Drug | oxybenzone | 2.02e-05 | 39 | 31 | 3 | CID000004632 | |
| Drug | 1y2g | 2.75e-05 | 129 | 31 | 4 | CID005287936 | |
| Drug | AC1L9K1W | 3.12e-05 | 45 | 31 | 3 | CID000446744 | |
| Drug | MSC194 | 4.29e-05 | 50 | 31 | 3 | CID003000663 | |
| Drug | MDL 18,962 | 5.00e-05 | 8 | 31 | 2 | CID000071996 | |
| Drug | 1XS7 | 9.43e-05 | 65 | 31 | 3 | CID000449218 | |
| Drug | Betamethasone [378-44-9]; Up 200; 10.2uM; HL60; HG-U133A | 1.07e-04 | 183 | 31 | 4 | 1590_UP | |
| Drug | Halcinonide [3093-35-4]; Up 200; 8.8uM; HL60; HT_HG-U133A | 1.10e-04 | 184 | 31 | 4 | 2185_UP | |
| Drug | Apigenin [520-36-5]; Down 200; 14.8uM; HL60; HT_HG-U133A | 1.10e-04 | 184 | 31 | 4 | 1321_DN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.12e-04 | 185 | 31 | 4 | 4755_DN | |
| Drug | Bluo-gal | 1.17e-04 | 12 | 31 | 2 | CID000126898 | |
| Drug | Triamcinolone [124-94-7]; Up 200; 10.2uM; HL60; HG-U133A | 1.19e-04 | 188 | 31 | 4 | 1395_UP | |
| Drug | Scoulerine [6451-73-6]; Up 200; 12.2uM; HL60; HG-U133A | 1.21e-04 | 189 | 31 | 4 | 1742_UP | |
| Drug | Apigenin [520-36-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.21e-04 | 189 | 31 | 4 | 4401_DN | |
| Drug | 5151277; Up 200; 14uM; MCF7; HT_HG-U133A_EA | 1.37e-04 | 195 | 31 | 4 | 903_UP | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.37e-04 | 195 | 31 | 4 | 5307_DN | |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.37e-04 | 195 | 31 | 4 | 3191_DN | |
| Drug | pirfenidone | 1.39e-04 | 13 | 31 | 2 | ctd:C093844 | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A | 1.40e-04 | 196 | 31 | 4 | 3762_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A | 1.40e-04 | 196 | 31 | 4 | 6934_UP | |
| Drug | Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; HL60; HG-U133A | 1.42e-04 | 197 | 31 | 4 | 1578_DN | |
| Drug | Nadide [53-84-9]; Down 200; 6uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 31 | 4 | 7227_DN | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 31 | 4 | 7012_DN | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A | 1.42e-04 | 197 | 31 | 4 | 3769_DN | |
| Drug | Pyrilamine maleate [59-33-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 31 | 4 | 7223_DN | |
| Drug | MK-886; Down 200; 1uM; MCF7; HG-U133A | 1.42e-04 | 197 | 31 | 4 | 601_DN | |
| Drug | 3-amino-4-phenylbutan-2-ol | 1.44e-04 | 75 | 31 | 3 | CID004634234 | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; HL60; HG-U133A | 1.45e-04 | 198 | 31 | 4 | 1415_DN | |
| Drug | Cefoperazone dihydrate; Up 200; 5.8uM; PC3; HT_HG-U133A | 1.45e-04 | 198 | 31 | 4 | 6323_UP | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 31 | 4 | 5325_DN | |
| Drug | Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.48e-04 | 199 | 31 | 4 | 3357_DN | |
| Drug | Benzonatate [104-31-4]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.48e-04 | 199 | 31 | 4 | 1679_UP | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 1.48e-04 | 199 | 31 | 4 | 4826_UP | |
| Drug | Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.48e-04 | 199 | 31 | 4 | 3346_DN | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; PC3; HT_HG-U133A | 1.51e-04 | 200 | 31 | 4 | 4095_DN | |
| Drug | 1pxm | 1.62e-04 | 78 | 31 | 3 | CID000447959 | |
| Disease | asthma (biomarker_via_orthology) | 3.61e-05 | 59 | 32 | 3 | DOID:2841 (biomarker_via_orthology) | |
| Disease | N-acetylhistidine measurement | 6.23e-05 | 11 | 32 | 2 | EFO_0800022 | |
| Disease | glaucoma (is_marker_for) | 2.14e-04 | 20 | 32 | 2 | DOID:1686 (is_marker_for) | |
| Disease | asthma (is_marker_for) | 3.44e-04 | 126 | 32 | 3 | DOID:2841 (is_marker_for) | |
| Disease | thoracic aortic aneurysm | 4.86e-04 | 30 | 32 | 2 | EFO_0004282 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HTNEPKAAHEYHPGS | 1316 | P78357 | |
| RKHHSPSPQHQDYVA | 2901 | Q8TCU4 | |
| AATPYLHHPGDSHSG | 6 | Q9GZQ3 | |
| AQEHNYSSPAGHHPH | 186 | Q8TE60 | |
| PHSTSGLYPHHTEHG | 711 | Q8HWS3 | |
| HHPGYLSDSHFIPDQ | 166 | P26045 | |
| PHHAYPGAGVAHDEL | 141 | Q9Y5Q3 | |
| HSLQDPFHGVYHSHP | 751 | Q9UDY8 | |
| HQHQHPPKGYGASVE | 226 | Q9NRM7 | |
| HYDSPKNSHIPGHYD | 1006 | Q5VY43 | |
| SAVHQHSYHPSGSKP | 66 | Q12986 | |
| HAQDGSSESSYKHHP | 26 | P98088 | |
| HHAFLSQGSAPYPHH | 1521 | P42694 | |
| HHPPSAAHYVFSKHG | 626 | Q969R2 | |
| KLDCHYSGHHPQPAS | 506 | O15265 | |
| HHPHSYREAPKGVDQ | 331 | Q96MD2 | |
| GQHPDTHHPGLSHSY | 21 | P23771 | |
| SSYQPIQPKDFHHHH | 491 | O75976 | |
| VGYHNEHHDFPNIPG | 256 | O15121 | |
| KNEGSYGGHHHPSAP | 116 | O43248 | |
| GKDSHHPARTAHYGS | 191 | P02686 | |
| VEHIPFSHNHYPEKE | 71 | Q6PHW0 | |
| GSAVHHPPSYVAHLA | 21 | P05121 | |
| NHVHGQPYTGPAAHH | 2511 | Q93008 | |
| SHHKKEHAGPDPHSQ | 296 | Q96MN9 | |
| FNKPDSHGGVPIHHY | 516 | O15394 | |
| HPQAHAPEYTSAHAP | 341 | A0A1B0GUW6 | |
| TGYHLGSPTAEHHPE | 1776 | Q8NI35 | |
| HSTHPDDEDSGPYKH | 606 | P24928 | |
| GTPSYGHTPSHHAAQ | 156 | P19544 | |
| QHHPIHTGEKPYECS | 276 | Q7Z398 | |
| AGSYSLSVPGHHHQK | 1011 | P31629 |